Unicycive Therapeutics, Inc. (UNCY) Financials
UNCY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 19.4 million | 16.0 million |
| 2023-06-30 | 22.9 million | 16.1 million |
| 2023-03-31 | 27.2 million | 16.7 million |
| 2022-12-31 | 2.8 million | 3.3 million |
UNCY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -4.4 million | 929000 |
| 2023-06-30 | -5.5 million | 144000 |
| 2023-03-31 | -3.9 million | 144000 |
| 2022-12-31 | -6.1 million | 197000 |
UNCY Net Income
No data available :(
UNCY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 14.3 million | - | 866000 |
| 2023-06-30 | 18.8 million | - | 937000 |
| 2023-03-31 | 24.3 million | - | 991000 |
| 2022-12-31 | 455000 | - | 155000 |
UNCY Shares Outstanding
UNCY Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 3.4 million | 2.6 million | - |
| 2023-06-30 | 12000 | 2.3 million | 2.1 million | - |
| 2023-03-31 | - | 3.0 million | 1.8 million | - |
| 2022-12-31 | 2000 | 3.8 million | 1.5 million | - |
UNCY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 79000 |
| 2023-06-30 | - | 78000 |
| 2023-03-31 | 675000 | 45000 |
| 2022-12-31 | - | 2000 |
UNCY
Price: $1.23
52 week price:
Earnings Per Share: -1.47 USD
P/E Ratio: -0.76
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 23619
Market Capitalization: 45.2 million